Current
$66.23B
5-Year Average
$83.51B
All-Time High
$138.68B
All-Time Low
$258.42M
Market cap daily chart for Regeneron Pharmaceuticals (REGN)
Jun 16, 2021 – Jun 15, 2026 · 1,255 trading days
Market Cap growth chart for Regeneron Pharmaceuticals (REGN) from 1991 to 2026
Latest: -21.0%
Market Cap history table for Regeneron Pharmaceuticals (REGN) from 1991 to 2026
| 2026 | $66.23B | -21.0% | −$17.59B | ||
| 2025 | $83.83B | +2.2% | +$1.84B | ||
| 2024 | $81.99B | -17.9% | −$17.87B | ||
| 2023 | $99.86B | +21.9% | +$17.97B | ||
| 2022 | $81.89B | +15.6% | +$11.03B | ||
| 2021 | $70.86B | +27.4% | +$15.25B | ||
| 2020 | $55.61B | +29.2% | +$12.58B | ||
| 2019 | $43.03B | +0.4% | +$152.21M | ||
| 2018 | $42.88B | -1.6% | −$699.38M | ||
| 2017 | $43.58B | +2.1% | +$884.61M | ||
| 2016 | $42.69B | -31.8% | −$19.86B | ||
| 2015 | $62.55B | +34.4% | +$16.01B | ||
| 2014 | $46.55B | +52.0% | +$15.92B | ||
| 2013 | $30.63B | +55.2% | +$10.89B | ||
| 2012 | $19.74B | +293.0% | +$14.72B | ||
| 2011 | $5.02B | +84.5% | +$2.30B | ||
| 2010 | $2.72B | +41.1% | +$793.33M | ||
| 2009 | $1.93B | +33.3% | +$481.87M | ||
| 2008 | $1.45B | -9.7% | −$154.70M | ||
| 2007 | $1.60B | +37.7% | +$438.51M | ||
| 2006 | $1.16B | +30.8% | +$273.85M | ||
| 2005 | $889.61M | +72.0% | +$372.26M | ||
| 2004 | $517.34M | -30.3% | −$224.77M | ||
| 2003 | $742.12M | -8.8% | −$71.39M | ||
| 2002 | $813.50M | -31.4% | −$371.70M | ||
| 2001 | $1.19B | -4.5% | −$55.39M | ||
| 2000 | $1.24B | +209.4% | +$839.62M | ||
| 1999 | $400.98M | +75.3% | +$172.20M | ||
| 1998 | $228.78M | -7.8% | −$19.46M | ||
| 1997 | $248.24M | -37.1% | −$146.36M | ||
| 1996 | $394.60M | +56.7% | +$142.81M | ||
| 1995 | $251.79M | +342.9% | +$194.93M | ||
| 1994 | $56.85M | -77.8% | −$199.77M | ||
| 1993 | $256.62M | +38.8% | +$71.78M | ||
| 1992 | $184.84M | -34.3% | −$96.49M | ||
| 1991 | $281.33M | — | — |
- 2026$66.23B-21.0%
- 2025$83.83B+2.2%
- 2024$81.99B-17.9%
- 2023$99.86B+21.9%
- 2022$81.89B+15.6%
- 2021$70.86B+27.4%
- 2020$55.61B+29.2%
- 2019$43.03B+0.4%
- 2018$42.88B-1.6%
- 2017$43.58B+2.1%
- 2016$42.69B-31.8%
- 2015$62.55B+34.4%
- 2014$46.55B+52.0%
- 2013$30.63B+55.2%
- 2012$19.74B+293.0%
- 2011$5.02B+84.5%
- 2010$2.72B+41.1%
- 2009$1.93B+33.3%
- 2008$1.45B-9.7%
- 2007$1.60B+37.7%
- 2006$1.16B+30.8%
- 2005$889.61M+72.0%
- 2004$517.34M-30.3%
- 2003$742.12M-8.8%
- 2002$813.50M-31.4%
- 2001$1.19B-4.5%
- 2000$1.24B+209.4%
- 1999$400.98M+75.3%
- 1998$228.78M-7.8%
- 1997$248.24M-37.1%
- 1996$394.60M+56.7%
- 1995$251.79M+342.9%
- 1994$56.85M-77.8%
- 1993$256.62M+38.8%
- 1992$184.84M-34.3%
- 1991$281.33M—
Market Cap values are taken from Regeneron Pharmaceuticals's reported income statements (share counts) and end-of-day prices (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Market Cap at Regeneron Pharmaceuticals (REGN)
According to Regeneron Pharmaceuticals's latest reported financial statements, the company's latest reported market cap is $83.21B. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2026 reading of Regeneron Pharmaceuticals (REGN) market cap is $66.23B – declined 21.0% year-over-year.
Regeneron Pharmaceuticals market cap has contracted on net over the period, with a -1.3% compound annual growth rate over 2021–2026 (5 years).
Between 2023 and 2026, Regeneron Pharmaceuticals market cap plunged 33.7%, falling from $99.86B to $66.23B.
Across the available history, market cap reached its high of $99.86B in 2023 and its low of $56.85M in 1994.
Regeneron Pharmaceuticals Market Cap by Year
Regeneron Pharmaceuticals Market Cap 2026: $66.23B
Regeneron Pharmaceuticals market cap in 2026 was $66.23B, declined 21.0% below 2025.
Regeneron Pharmaceuticals Market Cap 2025: $83.83B
2025's market cap for Regeneron Pharmaceuticals came in at $83.83B, edged up 2.2% from 2024.
Regeneron Pharmaceuticals Market Cap 2024: $81.99B
Regeneron Pharmaceuticals posted market cap of $81.99B in 2024, declined 17.9% below 2023.
Regeneron Pharmaceuticals Market Cap 2023: $99.86B
In 2023, Regeneron Pharmaceuticals reported market cap of $99.86B, grew 21.9% from 2022. This figure represents the highest annual value in the available history.
Regeneron Pharmaceuticals Market Cap 2022: $81.89B
Regeneron Pharmaceuticals market cap in 2022 was $81.89B.
See more financial history for Regeneron Pharmaceuticals (REGN).
Sector peers by Market Cap
Healthcare peers of Regeneron Pharmaceuticals (REGN), ranked by their latest market cap
| $1.06T | |
| $567.28B | |
| $391.50B | |
| $373.28B | |
| $283.78B | |
| $274.92B | |
| $195.17B | |
| $189.18B |
- $1.06T
- $567.28B
- $391.50B
- $373.28B
- $283.78B
- $274.92B
- $195.17B
- $189.18B
Frequently asked questions
Regeneron Pharmaceuticals (REGN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation